Weak Euro hits Fresenius profit estimates:
This article was originally published in Clinica
Executive Summary
Dialysis company Fresenius Medical Care (FMC) expects to have currency adjusted sales growth of over 10% this financial year, with a 25% increase in net income. The German company originally expected net income growth of up to 30%, but revised its estimates because of the weak euro in the first half, Bad Homburg-based FMC said. It has filed with the US Securities and Exchange Commission and the Frankfurt stock exchange for a global offering. It plans to use the proceeds to fund acquisitions (see Clinica No 914, p 9).
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.